In vitro effect of eltrombopag alone and in combination with azacitidine on megakaryopoiesis in patients with myelodysplastic syndrome

Thrombocytopenia is a severe complication for patients with myelodysplastic syndrome (MDS). Eltrombopag increases platelet count in MDS patients but its combination with azacitidine elicited controversial results. We aimed to quantify the colony forming units of megakaryocytes (CFU-Mk) obtained from...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Francesco D’Alò, Ilaria Zangrilli, Elisa Cupelli, Luana Fianchi, Marianna Criscuolo, Giulia Falconi, Emiliano Fabiani, Livio Pagano, Stefan Hohaus, Valerio De Stefano
Format:	Artigo
Jezik:	Inglês
Izdano:	Taylor & Francis Group 2021-04-01
Serija:	Platelets
Teme:	azacitidine eltrombopag megakaryopoiesis myelodysplastic syndromes
Online dostop:	http://dx.doi.org/10.1080/09537104.2020.1742312
Oznake:	Označite Brez oznak, prvi označite!